https://orcid.org/0000-0002-2951-7455
References
- Consistent with nationwide trends, overdose deaths rise in New York City in first quarter of 2020 [press release]. New York, NY. https://www1.nyc.gov/site/doh/about/press/pr2020/overdose-deaths-rise-in-nyc.page. Published December 30, 2020.
- Khoury D, Preiss A, Geiger P, Anwar M, Conway KP. Increases in naloxone administrations by emergency medical services providers during the COVID-19 pandemic: retrospective time series study. JMIR Public Health Surveill. 2021;7(5):e29298.
- Rodda LN, West KL, LeSaint KT. Opioid overdose-related emergency department visits and accidental deaths during the COVID-19 pandemic. J Urban Health. 2020;97(6):988–813.
- Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176.
- Collins AB, Ndoye CD, Arene-Morley D, Marshall BDL. Addressing co-occurring public health emergencies: the importance of naloxone distribution in the era of COVID-19. Int J Drug Policy. 2020;83:102872.
- O’Donoghue AL, Biswas N, Dechen T, et al. Trends in filled naloxone prescriptions before and during the COVID-19 pandemic in the United States. JAMA Health Forum. 2021;2(5):e210393–e210393.
- Wu S, Frey T, Wenthur CJ. Naloxone acceptance by outpatient veterans: a risk-prioritized telephone outreach event. Res Social Admin Pharm. 2021;17(5):1017–1020.
- Courser MW, Raffle H. With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic. J Subst Abuse Treat. 2021;122:108220–108220.
- French R, Favaro J, Aronowitz SV. A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic. Int J Drug Policy. 2021;94:103199.
- Clarke H, Weinrib A, Kotteeswaran Y, Katz J, Yu A, Tanguay R. Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: case reports, clinical pathways, and implications for the future. Can J Pain. 2020;4(1):224–235.
- Daskalakis G, Cid A, Grindrod K, Beazely MA. Investigating community pharmacy take home naloxone dispensing during COVID-19: the impact of one public health crisis on another. Pharmacy 2021;9(3):129.
- Barnett BS, Wakeman SE, Davis CS, Favaro J, Rich JD. Expanding mail-based distribution of drug-related harm reduction supplies amid COVID-19 and beyond. Am J Public Health. 2021;111(6):1013–1017.
- Sinai I. Respectful and Equitable Access to Comprehensive Healthcare (REACH) Program. https://www.mountsinai.org/care/primary-care/upper-east-side/ima/reach. Published 2020. Accessed December 24, 2020.
- Lee TG, Herscher M, Navalurkar R, et al. 'REACH-IN': using the inpatient encounter to expand access to primary care-based treatment for opioid use disorder. J Gen Intern Med. 2019;34(2):99–867.
- Navalurkar R, Wang L, Lee TG, et al. REACH-IN’: a hospital-based initiative to confront the opioid epidemic. Abstracts from the 2019 Annual Meeting of the Society of Hospital Medicine. J Hosp Med. 2019.
- Bahethi RR, Liu BY, Asriel B, et al. The COVID-19 student workforce at the Icahn School of Medicine at Mount Sinai: a model for rapid response in emergency preparedness. Acad Med. 2021;96(6):859–863.
- Kestler A, Buxton J, Meckling G, et al. Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Ann Emerg Med. 2017;69(3):340–346.
- Skoy E, Werremeyer A, Steig J, Eukel H, Frenzel O, Strand M. Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose. Substance Abuse 2020;42(4):672–677.
- Berland N, Fox A, Tofighi B, Hanley K. Opioid overdose prevention training with naloxone, an adjunct to basic life support training for first-year medical students. Substance Abuse. 2017;38(2):123–128.
- Wilson JD, Spicyn N, Matson P, Alvanzo A, Feldman L. Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings. Subst Abus. 2016;37(3):480–487.
- Hargraves D, White CC, Mauger MR, et al. Evaluation of an interprofessional naloxone didactic and skills session with medical residents and physician assistant learners. Pharm Pract. 2019;17(3):1591–1591.
- Berland N, Lugassy D, Fox A, et al. Use of online opioid overdose prevention training for first-year medical students: a comparative analysis of online versus in-person training. Subst Abus. 2019;40(2):240–246.